Cargando…

LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β

Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC), especially in BRAF‐like PTC, by analyzing The Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wei‐Jun, Zhu, Liu‐Lian, Yang, Wei‐Qiang, Xu, Shuai‐Jun, Chen, Jie, Ding, Xiao‐Fei, Liang, Yong, Chen, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019227/ https://www.ncbi.nlm.nih.gov/pubmed/33540491 http://dx.doi.org/10.1111/cas.14837

Ejemplares similares

Class IA PI3K regulatory subunits: p110-independent roles and structures
por: Fox, Millie, et al.
Publicado: (2020)

The class IA phosphatidylinositol 3-kinase p110-β subunit is a positive regulator of autophagy
por: Dou, Zhixun, et al.
Publicado: (2010)

Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors
por: Tsolakos, N., et al.
Publicado: (2018)

The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
por: Pridham, Kevin J., et al.
Publicado: (2017)

The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis
por: Montes-Casado, María, et al.
Publicado: (2021)

Class IA Phosphatidylinositol 3-Kinase p110α Regulates Phagosome Maturation
por: Thi, Emily P., et al.
Publicado: (2012)

Reduction of LPAR1 Expression in Neuroblastoma Promotes Tumor Cell Migration
por: Liu, Xiangjun, et al.
Publicado: (2022)

Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis
por: Shi, Yijun, et al.
Publicado: (2020)

T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response
por: Aragoneses-Fenoll, Laura, et al.
Publicado: (2018)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders
por: Gross, Christina, et al.
Publicado: (2014)

In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity
por: Kuriyama, Sei, et al.
Publicado: (2014)

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase
por: Colamonici, Marco, et al.
Publicado: (2015)

PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits
por: Wang, Qi, et al.
Publicado: (2020)

microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019)

The Phosphoinosotide 3-Kinase Catalytic Subunit p110α is Required for Normal Lens Growth
por: Sellitto, Caterina, et al.
Publicado: (2016)

Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
por: Zhang, Ben, et al.
Publicado: (2023)

Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases
por: Hon, Wai-Ching, et al.
Publicado: (2011)

The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110α catalytic subunit
por: Pennino, Francesco Paolo, et al.
Publicado: (2021)

Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
por: Brusevold, Ingvild J, et al.
Publicado: (2014)

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)

An LPAR(5)-antagonist that reduces nociception and increases pruriception
por: Langedijk, Jacqueline, et al.
Publicado: (2022)

Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study
por: Younis, Saima, et al.
Publicado: (2017)

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2016)

Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway
por: Kim, Donghee, et al.
Publicado: (2021)

Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5
por: Lei, Li, et al.
Publicado: (2021)

Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family
por: Poopal, Ashwini C., et al.
Publicado: (2016)

The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Class I hysterectomy in stage Ia2-Ib1 cervical cancer
por: Chen, Long, et al.
Publicado: (2018)

Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism
por: Li, Mengyao Ella, et al.
Publicado: (2019)

Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2020)

Infiltration of LPAR5(+) macrophages in osteosarcoma tumor microenvironment predicts better outcomes
por: He, Yi, et al.
Publicado: (2022)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)

LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway
por: Sun, Xiao-Ya, et al.
Publicado: (2022)

Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line
por: Rivera, Richard, et al.
Publicado: (2021)

Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia
por: Bucher, Kirsten, et al.
Publicado: (2017)

Signaling via Class IA Phosphoinositide 3-Kinases (PI3K) in Human, Breast-Derived Cell Lines
por: Juvin, Veronique, et al.
Publicado: (2013)

Insights into the Mechanisms Involved in Strong Hemorrhage and Dermonecrosis Induced by Atroxlysin-Ia, a PI-Class Snake Venom Metalloproteinase
por: Freitas-de-Sousa, Luciana Aparecida, et al.
Publicado: (2017)

ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway
por: Xia, Wu, et al.
Publicado: (2020)

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment
por: Luo, Ya-Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_60oupn27o8kh149ge3m584u4bp